Dr. Dmitry Kryndushkin is registered to practice before the U.S. Patent & Trademark Office (Registration No.: 71,818) and is an accomplished patent agent with 15 years of scientific and regulatory expertise in the biotechnology and pharmaceutical arts.
Dmitry’s experience includes working as Director of Intellectual Property in a biotechnology company, with leading of many aspects of IP protection, including soliciting new inventions, drafting patent applications, performing prosecution in the US and abroad, and managing strategic development of the IP portfolio of patents (> 5 years). Dmitry’s prior experience includes working as Senior Patent Agent in a highly regarded law firm where he prepared and prosecuted a multitude of utility patent applications in both the United States and internationally and coordinated the preparation and prosecution of patent applications in many foreign jurisdictions, contributed to preparation of Freedom-to-Operate and patentability opinions.
Dmitry was included in the IAM Patent 1000-The World's Leading Patent Professionals (2019-2020). He also served as a primary reviewer of U.S. PCT patent applications related to biotechnology and pharmaceutical inventions, preparing International Search Reports and Written Opinions.
Dmitry has extensive research experience in the life sciences and healthcare fields and is an author of more than 30 peer-reviewed publications in international journals.
He was a regulatory scientist at the U.S. Food and Drug Administration (FDA, Center for Drug Evaluation and Research, Office of Biotechnology Products) and a postdoctoral scientist at the National Institutes of Health (NIH).
Dmitry holds a Ph.D. degree in Molecular Biophysics from the Institute of Physics and Technology (MIPT, Moscow, Russia), B.S. in Applied Mathematics and Physics from MIPT, and Regulatory Affairs Certification from Regulatory Affairs Professional Society (RAPS, USA).
Dmitry’s experience includes working as Director of Intellectual Property in a biotechnology company, with leading of many aspects of IP protection, including soliciting new inventions, drafting patent applications, performing prosecution in the US and abroad, and managing strategic development of the IP portfolio of patents (> 5 years). Dmitry’s prior experience includes working as Senior Patent Agent in a highly regarded law firm where he prepared and prosecuted a multitude of utility patent applications in both the United States and internationally and coordinated the preparation and prosecution of patent applications in many foreign jurisdictions, contributed to preparation of Freedom-to-Operate and patentability opinions.
Dmitry was included in the IAM Patent 1000-The World's Leading Patent Professionals (2019-2020). He also served as a primary reviewer of U.S. PCT patent applications related to biotechnology and pharmaceutical inventions, preparing International Search Reports and Written Opinions.
Dmitry has extensive research experience in the life sciences and healthcare fields and is an author of more than 30 peer-reviewed publications in international journals.
He was a regulatory scientist at the U.S. Food and Drug Administration (FDA, Center for Drug Evaluation and Research, Office of Biotechnology Products) and a postdoctoral scientist at the National Institutes of Health (NIH).
Dmitry holds a Ph.D. degree in Molecular Biophysics from the Institute of Physics and Technology (MIPT, Moscow, Russia), B.S. in Applied Mathematics and Physics from MIPT, and Regulatory Affairs Certification from Regulatory Affairs Professional Society (RAPS, USA).
